Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: Aliment Pharmacol Ther. 2023 Apr 13;57(11):1272–1289. doi: 10.1111/apt.17479

Figure 3. Subgroup variation in the 4-week change from baseline in early satiety/postprandial fullness subscore between treatment groups using prespecified baseline post-randomization subgroups.

Figure 3.

Subgroups displayed are: 1) Etiology: Diabetic vs Idiopathic, 2) Bloating: Severe/very severe vs none to moderate, 3) Water Load Satiety Test volume consumed: Low vs Normal, 4) Narcotic use 3+ times/week or less: No use vs used.